Director, Molecular Pharmacology

Overview

At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you can also count on us to develop creative solutions to support communities through philanthropy and volunteerism.

The Lilly Small Molecule Design group is an organization purpose-built to create molecules that make life better for people. We focus on using cutting‑edge science to unlock new approaches that can treat people suffering from diseases with poor treatment options. We continually challenge ourselves to deliver molecules that can provide breakthrough efficacy with the highest possible safety margins. We are dedicated to optimizing our mindset, technology, and processes for faster, more nimble execution.

Our success is built on a culture that empowers innovative problem‑solving through open collaboration and individual accountability.

The Advanced Molecule Design team's mission is to optimize lead molecules to strong drug candidates that become breakthrough medicines. We are searching for experienced and engaged scientific experts who are recognized authorities in their area of focus and drive the advancement of our portfolio across oncology, immunology, pain, Alzheimer's, diabetes, and obesity. These positions are for seasoned drug hunters who ask the right scientific questions and collect high‑impact data to drive projects forward.

To be successful, these experts will provide deep scientific knowledge across multiple programs or therapeutic areas, build capabilities that enhance Molecular Pharmacology's impact on the portfolio, and help deliver quality drug candidates to IND. We are looking for innovative scientists with a strong growth mindset who can challenge dogma and champion breakthrough approaches.

• Design, develop, and execute molecular pharmacology assays and flow schemes to support drug discovery programs, with emphasis on:–
  1) Radioligand binding (competition, saturation, kinetic assays, autoradiography)
  2) GPCR internalization and receptor trafficking assays and
  3) Imaging‑based assays including confocal microscopy and/or high content screening (HCS)

• Develop novel, fit‑for‑purpose assay platforms from the ground up, including assay design, reagent optimization, cell line selection/engineering, and qualification for drug discovery use

• Characterize compound pharmacology and mechanisms of action including receptor affinity, selectivity, and functional activity (e.g., G protein signaling, arrestin recruitment, receptor desensitization)

• Serve as a recognized expert in their field, providing scientific leadership that shapes program strategy and builds credibility across the organization.

• Provide expert scientific guidance that shapes project strategy and improves probability of technical success across multiple programs or therapeutic areas.

• Identify capability gaps and develop solutions that benefit multiple programs across the portfolio.

• Actively incorporate state‑of‑the‑art methods and technologies

• Incorporate AI/ML into scientific workflows.

• Foster an environment that supports open scientific debate and bold, evidence‑based decisions.

• Actively mentor and develop diverse scientific talent across sites and functions.

• Lead cross‑functional initiatives that leverage diverse perspectives to drive program outcomes.

• Champion a ONE TEAM, SAME TEAM mindset; model radical transparency in surfacing challenges.

• Identify and contribute to external innovation opportunities that strengthen the portfolio.

• Build internal and external networks that enhance the capabilities of the Molecular Pharmacology team.

• PhD with a minimum of 10+ years of drug discovery experience in the pharmaceutical industry; or BS/MS with 15+ years of equivalent experience.

• Degree in Biochemistry, Biology, Biophysics, Molecular Biology, Pharmacology, or related fields.

• Demonstrated expertise in molecular pharmacology assay development, including radioligand binding and/or imaging‑based…